The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal ... "It offers the potential to detect colorectal cancer in a person who is non-adherent ...

The Food and Drug Administration approved a blood test intended to detect colorectal cancer on Monday ... risk and not experiencing symptoms. "The FDA approval of the Shield test is a significant ...

Earlier this year, an FDA advisory panel -- the ... the company’s first blood-based test for the detection of early-stage colorectal cancer. Guardant Health In clinical trial data, published ...

Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

The blood test, known as Shield and manufactured by Guardant Health, is already commercially available, but FDA approval ... improve colorectal cancer screening rates so we can detect more cancers ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. The United States Food and Drug Administration (FDA) approved a new ...

NOW, TODAY, THE FDA APPROVED THAT BLOOD TEST TO SCREEN FOR COLON CANCER. IN SOME PEOPLE, THE BLOOD TEST, WHICH IS CALLED SHIELD, IS ALREADY AVAILABLE. BUT FDA APPROVAL WILL HELP MAKE IT MORE ...

Guardant Health, the California company that created the test, said Monday that Shield is the first blood test approved by the FDA as a ... available to detect colorectal cancer early while ...